Devyser announces study publication demonstrating dd-cfDNA detection in dual donor kidney transplant patients
Devyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
In this webinar, you will learn about Devyser’s new solution for HLA loss detection, designed to support researchers and laboratories studying post-transplant relapse pathways.
Here’s why you should watch this webinar:
1. Explore the role of HLA loss in post-transplant relapse
Gain insights into how HLA loss contributes to relapse in allogeneic hematopoietic stem cell transplantation (allo-HSCT), and why it matters in the context of haplo-SCT and MMUD.
2. Discover an NGS assay for HLA loss detection
Learn how Devyser HLA Loss offers a fast, efficient workflow with a single-tube solution for generating target-specific libraries for NGS analysis and enables the detection of 25 HLA locus-specific markers, 5 chromosome-specific genetic markers, and 4 ID markers.
3. Enhance your translational research
Understand how this tool can support studies on immune surveillance and relapse pathways, helping bridge research and future clinical practice.
Disclaimer: For research use only. Not for use in diagnostic procedures.
News | October 29, 2024
Devyser seeks to secure FDA approval for NGS test for kidney transplant monitoringNews | October 28, 2024
Devyser Compact achieves Class III approval in ChinaDevyser Diagnostics AB announces today an article titled “Detection of donor-derived cell-free DNA...
Read More
Read More
Devyser’s novel test for detecting donor-derived cell-free DNA in blood samples from...
Read More
A better patient care is the final objective for Dr. Helena Devos and the team at Sint Jan’s...
Read More